Home
>
National Drug Code (NDC)
>
pioglitazone hydrochloride
pioglitazone hydrochloride - 51991-709-33 - (pioglitazone hydrochloride)
Drug Information of pioglitazone hydrochloride
| Product NDC: | 51991-709 |
| Proprietary Name: | pioglitazone hydrochloride |
| Non Proprietary Name: | pioglitazone hydrochloride |
| Active Ingredient(s): | 30 mg/1 & nbsp; pioglitazone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of pioglitazone hydrochloride
| Product NDC: | 51991-709 |
| Labeler Name: | Breckenridge Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078472 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130213 |
Package Information of pioglitazone hydrochloride
| Package NDC: | 51991-709-33 |
| Package Description: | 30 TABLET in 1 BOTTLE (51991-709-33) |
NDC Information of pioglitazone hydrochloride
| NDC Code | 51991-709-33 |
| Proprietary Name | pioglitazone hydrochloride |
| Package Description | 30 TABLET in 1 BOTTLE (51991-709-33) |
| Product NDC | 51991-709 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pioglitazone hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130213 |
| Marketing Category Name | ANDA |
| Labeler Name | Breckenridge Pharmaceutical, Inc. |
| Substance Name | PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |
